Materazzi S - Search Results

1

Analysis of protease-activated receptor-1 and -2 in human scar formation.

Materazzi S, Pellerito S, Di Serio C, Paglierani M, Naldini A, Ardinghi C, Carraro F, Geppetti P, Cirino G, Santucci M, Tarantini F, Massi D. Materazzi S, et al. J Pathol. 2007 Aug;212(4):440-9. doi: 10.1002/path.2197. J Pathol. 2007. PMID: 17597495

2

Protease-activated receptor-2 downregulation is associated to vitiligo lesions.

Moretti S, Nassini R, Prignano F, Pacini A, Materazzi S, Naldini A, Simoni A, Baroni G, Pellerito S, Filippi I, Lotti T, Geppetti P, Massi D. Moretti S, et al. Among authors: materazzi s. Pigment Cell Melanoma Res. 2009 Jun;22(3):335-8. doi: 10.1111/j.1755-148X.2009.00562.x. Epub 2009 Mar 6. Pigment Cell Melanoma Res. 2009. PMID: 19368691 No abstract available.

3

The transient receptor potential vanilloid 1: role in airway inflammation and disease.

Geppetti P, Materazzi S, Nicoletti P. Geppetti P, et al. Among authors: materazzi s. Eur J Pharmacol. 2006 Mar 8;533(1-3):207-14. doi: 10.1016/j.ejphar.2005.12.063. Epub 2006 Feb 7. Eur J Pharmacol. 2006. PMID: 16464449 Review.

4

Cough sensors. II. Transient receptor potential membrane receptors on cough sensors.

Materazzi S, Nassini R, Gatti R, Trevisani M, Geppetti P. Materazzi S, et al. Handb Exp Pharmacol. 2009;(187):49-61. doi: 10.1007/978-3-540-79842-2_3. Handb Exp Pharmacol. 2009. PMID: 18825335 Review.

5

Transient receptor potential vanilloid 4 (TRPV4) is downregulated in keratinocytes in human non-melanoma skin cancer.

Fusi C, Materazzi S, Minocci D, Maio V, Oranges T, Massi D, Nassini R. Fusi C, et al. Among authors: materazzi s. J Invest Dermatol. 2014 Sep;134(9):2408-2417. doi: 10.1038/jid.2014.145. Epub 2014 Mar 18. J Invest Dermatol. 2014. PMID: 24643128 Free article.

6

The concept of neurogenic inflammation.

Geppetti P, Nassini R, Materazzi S, Benemei S. Geppetti P, et al. Among authors: materazzi s. BJU Int. 2008 Mar;101 Suppl 3:2-6. doi: 10.1111/j.1464-410X.2008.07493.x. BJU Int. 2008. PMID: 18307678 Review.

7

Cough: The Emerging Role of the TRPA1 Channel.

Geppetti P, Patacchini R, Nassini R, Materazzi S. Geppetti P, et al. Among authors: materazzi s. Lung. 2010 Jan;188 Suppl 1:S63-8. doi: 10.1007/s00408-009-9201-3. Epub 2009 Nov 30. Lung. 2010. PMID: 20091046 Review.

8

Keep in Mind TRPA1 When Prescribing Metamizole!

Benemei S, Nassini R, Materazzi S, Geppetti P. Benemei S, et al. Among authors: materazzi s. Pain Pract. 2016 Sep;16(7):E110. doi: 10.1111/papr.12486. Pain Pract. 2016. PMID: 27600926 No abstract available.

9

The TRPA1 channel in inflammatory and neuropathic pain and migraine.

Nassini R, Materazzi S, Benemei S, Geppetti P. Nassini R, et al. Among authors: materazzi s. Rev Physiol Biochem Pharmacol. 2014;167:1-43. doi: 10.1007/112_2014_18. Rev Physiol Biochem Pharmacol. 2014. PMID: 24668446 Review.

10

Transient receptor potential channels as novel drug targets in respiratory diseases.

Nassini R, Materazzi S, De Siena G, De Cesaris F, Geppetti P. Nassini R, et al. Among authors: materazzi s. Curr Opin Investig Drugs. 2010 May;11(5):535-42. Curr Opin Investig Drugs. 2010. PMID: 20419599 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters